• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-326:在脑癌中的作用及意义

MiR-326: Role and significance in brain cancers.

作者信息

Spinello Zaira, Besharat Zein Mersini, Mainiero Fabrizio, Rughetti Aurelia, Masuelli Laura, Ferretti Elisabetta, Catanzaro Giuseppina

机构信息

Department of Experimental Medicine, Sapienza University of Rome, 00161, Rome, Italy.

Department of Life Science, Health, and Health Professions, Link Campus University, 00165, Rome, Italy.

出版信息

Noncoding RNA Res. 2025 Feb 25;12:56-64. doi: 10.1016/j.ncrna.2025.02.006. eCollection 2025 Jun.

DOI:10.1016/j.ncrna.2025.02.006
PMID:40115178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11925037/
Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that act as critical regulators of gene expression by repressing mRNA translation. The role of miRNAs in cell physiology spans from cell cycle control to cell proliferation and differentiation, both during development and in adult tissues. Accordingly, dysregulated expression of miRNAs has been reported in several diseases, including cancer, where miRNAs can act as oncogenes or oncosuppressors. Of note, miRNA signatures are also under investigation for classification, diagnosis, and prognosis of cancer patients. Brain tumours are primarily associated with poor prognosis and high mortality, highlighting an urgent need for novel diagnostic, prognostic, and therapeutic tools. Among miRNAs investigated in brain tumours, miR-326 has been shown to act as a tumour suppressor in adult and paediatric brain cancers. In this review, we describe the role of miR-326 in malignant as well as benign cancers originating from brain tissue. In addition, since miR-326 expression can be regulated by other non-coding RNA species, adding a further layer of regulation in the cancer-promoting axis, we discuss this miRNA's role in targeted therapy for brain cancers.

摘要

微小RNA(miRNA)是一类小的非编码RNA,通过抑制mRNA翻译来充当基因表达的关键调节因子。miRNA在细胞生理学中的作用涵盖从细胞周期控制到细胞增殖和分化,在发育过程以及成年组织中均是如此。因此,在包括癌症在内的多种疾病中均报道了miRNA表达失调的情况,其中miRNA可作为癌基因或抑癌基因发挥作用。值得注意的是,miRNA特征也正在被研究用于癌症患者的分类、诊断和预后评估。脑肿瘤主要与预后不良和高死亡率相关,这凸显了对新型诊断、预后和治疗工具的迫切需求。在脑肿瘤中研究的miRNA中,miR-326已被证明在成人和儿童脑癌中作为肿瘤抑制因子发挥作用。在本综述中,我们描述了miR-326在源自脑组织的恶性以及良性癌症中的作用。此外,由于miR-326的表达可受其他非编码RNA种类的调控,这在癌症促进轴中增加了另一层调控,我们讨论了这种miRNA在脑癌靶向治疗中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12e/11925037/8e7dabc3b8e0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12e/11925037/2382ae859d08/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12e/11925037/3fa9b8137ed0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12e/11925037/8e7dabc3b8e0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12e/11925037/2382ae859d08/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12e/11925037/3fa9b8137ed0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12e/11925037/8e7dabc3b8e0/gr3.jpg

相似文献

1
MiR-326: Role and significance in brain cancers.微小RNA-326:在脑癌中的作用及意义
Noncoding RNA Res. 2025 Feb 25;12:56-64. doi: 10.1016/j.ncrna.2025.02.006. eCollection 2025 Jun.
2
The Role of microRNAs, Long Non-coding RNAs, and Circular RNAs in Cervical Cancer.微小RNA、长链非编码RNA和环状RNA在宫颈癌中的作用
Front Oncol. 2020 Feb 20;10:150. doi: 10.3389/fonc.2020.00150. eCollection 2020.
3
Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target.miRNA-330 在癌症中的失调表达和功能:一个潜在的治疗靶点。
Biomed Pharmacother. 2022 Feb;146:112600. doi: 10.1016/j.biopha.2021.112600. Epub 2021 Dec 27.
4
Interplay between lncRNA/miRNA and Wnt/ß-catenin signaling in brain cancer tumorigenesis.lncRNA/miRNA与Wnt/β-连环蛋白信号通路在脑癌肿瘤发生中的相互作用。
EXCLI J. 2023 Nov 28;22:1211-1222. doi: 10.17179/excli2023-6490. eCollection 2023.
5
Diagnostic, grading and prognostic role of a restricted miRNAs signature in primary and metastatic brain tumours. Discussion on their therapeutic perspectives.原发性和转移性脑肿瘤受限 miRNA 特征的诊断、分级和预后作用。探讨其治疗前景。
Mol Genet Genomics. 2022 Mar;297(2):357-371. doi: 10.1007/s00438-021-01851-5. Epub 2022 Jan 21.
6
Methylation of the miR-126 gene associated with glioma progression.与胶质瘤进展相关的miR-126基因甲基化
Fam Cancer. 2016 Apr;15(2):317-24. doi: 10.1007/s10689-015-9846-4.
7
The Oncogenic and Tumor Suppressive Long Non-Coding RNA-microRNA-Messenger RNA Regulatory Axes Identified by Analyzing Multiple Platform Omics Data from Cr(VI)-Transformed Cells and Their Implications in Lung Cancer.通过分析六价铬转化细胞的多平台组学数据鉴定出的致癌和抑癌长链非编码RNA-微小RNA-信使RNA调控轴及其在肺癌中的意义
Biomedicines. 2022 Sep 20;10(10):2334. doi: 10.3390/biomedicines10102334.
8
Role of miRNA-19a in Cancer Diagnosis and Poor Prognosis.微小RNA-19a在癌症诊断及预后不良中的作用
Int J Mol Sci. 2021 Apr 29;22(9):4697. doi: 10.3390/ijms22094697.
9
CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.环状 CCNA1 沉默作为 miR-106b-5p 的海绵吸附物抑制 GPM6A 表达,通过增强 DYNC1I1 表达和激活 AKT/ERK 信号通路促进 HCC 进展。
Int J Biol Sci. 2022 Jan 1;18(2):637-651. doi: 10.7150/ijbs.66915. eCollection 2022.
10
Identification of Novel Long Non-coding and Circular RNAs in Human Papillomavirus-Mediated Cervical Cancer.人乳头瘤病毒介导的宫颈癌中新型长链非编码RNA和环状RNA的鉴定
Front Microbiol. 2017 Sep 19;8:1720. doi: 10.3389/fmicb.2017.01720. eCollection 2017.

本文引用的文献

1
Trials and Tribulations of MicroRNA Therapeutics.miRNA 治疗的困境与挑战
Int J Mol Sci. 2024 Jan 25;25(3):1469. doi: 10.3390/ijms25031469.
2
Surgical Management and Advances in the Treatment of Glioma.脑胶质瘤的外科治疗及进展。
Semin Neurol. 2023 Dec;43(6):810-824. doi: 10.1055/s-0043-1776766. Epub 2023 Nov 14.
3
Primary brain tumours in adults.成人原发性脑肿瘤。
Lancet. 2023 Oct 28;402(10412):1564-1579. doi: 10.1016/S0140-6736(23)01054-1. Epub 2023 Sep 19.
4
MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies.微小 RNA:癌症诊断和治疗策略临床试验的趋势。
Exp Mol Med. 2023 Jul;55(7):1314-1321. doi: 10.1038/s12276-023-01050-9. Epub 2023 Jul 10.
5
Cancer stem cells, not bulk tumor cells, determine mechanisms of resistance to SMO inhibitors.肿瘤干细胞而非肿瘤细胞群体决定了对 SMO 抑制剂耐药的机制。
Cancer Res Commun. 2022 Jun;2(6):402-416. doi: 10.1158/2767-9764.crc-22-0124. Epub 2022 Jun 6.
6
The hallmarks of cancer… in pituitary tumors?癌症的特征……在垂体肿瘤中?
Rev Endocr Metab Disord. 2023 Apr;24(2):177-190. doi: 10.1007/s11154-022-09777-y. Epub 2022 Dec 31.
7
Non-coding RNAs and glioma: Focus on cancer stem cells.非编码RNA与神经胶质瘤:聚焦于癌症干细胞。
Mol Ther Oncolytics. 2022 Sep 17;27:100-123. doi: 10.1016/j.omto.2022.09.005. eCollection 2022 Dec 15.
8
Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity.脑肿瘤干细胞:通过适应性可塑性和层级异质性实现的韧性。
Nat Rev Cancer. 2022 Sep;22(9):497-514. doi: 10.1038/s41568-022-00486-x. Epub 2022 Jun 16.
9
Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma.肿瘤细胞异质性和可塑性:胶质母细胞瘤的范式转变。
Neuro Oncol. 2022 May 4;24(5):669-682. doi: 10.1093/neuonc/noab269.
10
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence.人类髓母细胞瘤治疗耐药性的时间动态分析确定了复发的新型可靶向驱动因素。
Sci Adv. 2021 Dec 10;7(50):eabi5568. doi: 10.1126/sciadv.abi5568. Epub 2021 Dec 8.